Why are Medicare and Medicaid shown separately instead of combined?

They come from two different CMS data sources with no shared claim identifier, so they can't be reconciled into one number without double-counting or guessing. Every table and chart on this page keeps them fully separate.

Why is there no private/commercial revenue figure?

Private and commercial payer data comes from Transparency in Coverage files, which only publish negotiated rates — not claims or utilization volume. Without a volume figure, no revenue number can be computed for any provider from that data.

What does "Rank" mean in the Competitive Analysis & Benchmarks tables?

For a given CPT/HCPCS code, it's this provider's position by claims volume among all providers billing that same code at that geography level (State, National, or New Mexico for Medicaid) — rank 1 means the highest claims volume for that code.

Why is the Medicaid comparison limited to New Mexico only?

Medicaid is administered per-state with no single national fee schedule, so a state or national comparison the way Medicare has one isn't available. New Mexico (this provider's own state) is the only grouping that's conceptually meaningful.

Why are the numbers rounded to the nearest 10?

To avoid implying more precision than the underlying data supports at a single-provider level. Ratios are kept precise since they're a relative comparison, not a volume or dollar figure.

How current is this data?

The Medicare and Medicaid tables are both single current snapshots, not refreshed on a recurring schedule yet.

Christopher Roybal (NPI 1639375397)

Field	Value
Entity Type	Individual
Organization	Christopher Roybal
Address	6401 Holly Ave Ne
City	Albuquerque
State	NM
ZIP	87113
Taxonomy	Ophthalmology Physician
NPI Enumerated	June 21, 2007

Payer Source	Total Paid
Medicare	$3.8M
Medicaid	$0

Key Findings

Provider is effectively a Medicare-only biller with total Medicare revenue of $3.8M and no Medicaid billing on file; their NPI was enumerated 2007-06-21 (~19 years ago), indicating nearly two decades of billing history under this provider identifier. This single-payer concentration implies Medicare fee schedules and beneficiary referral patterns will dominate the provider’s revenue profile and contracting leverage.

Revenue is highly concentrated in three intravitreal drug codes: J2777 ($1.3M revenue, 33.3% of total Medicare revenue), J0178 ($1.1M revenue, 29.9% of total Medicare revenue), and J2778 ($832.1K revenue, 22.1% of total Medicare revenue); these top three codes together account for 85.2% of the provider’s Medicare revenue. The practice’s financial performance therefore depends overwhelmingly on biologic injection services rather than office-based evaluation and management.

Clinical/service-line mix is centered on retina therapeutics and procedure-driven ophthalmology: very high volumes of intravitreal injections (J2777: 43.3K claims, $29 avg paid/claim; J2778: 4.6K claims, $182 avg paid/claim; J0178: 1.6K claims, $693 avg paid/claim) paired with significant retinal imaging (92134: 1.9K claims) and some vitrectomy/retinal surgery codes (67042: 62 claims). This pattern indicates the practice operates primarily as a medical retina center delivering frequent injection visits and supporting diagnostics rather than a general ophthalmology clinic.

Payer mix is lopsided toward Medicare — Medicaid shows none on file — so the provider functions as essentially single-payer (Medicare) in available data. That concentration raises exposure to Medicare reimbursement policy changes for high-cost ophthalmic drugs and procedural codes that drive most revenue.

Competitive standing differs by drug: J2778 ranks #54 of 1208 providers nationally (96th percentile; described in source as typical, unremarkable volume), placing this provider near the top nationally for ranibizumab billing; J2777 ranks #145 of 2039 (93th percentile; typical, unremarkable volume) and J0178 ranks #733 of 3204 (77th percentile; typical, unremarkable volume), indicating above-average to strong national presence for these retinal injection codes but with varying degrees of market dominance across agents. In short, the provider is a major national contributor for ranibizumab volumes and a solid, above-average contributor for the other top biologics.

Office visit and evaluation-and-management codes contribute little to revenue compared with injections: 92014 generated $88.8K (2.4% of Medicare revenue) and 99214 produced $21.6K (0.6% of Medicare revenue), while new patient comprehensive visits (92004) accounted for $16.4K (0.4%). This confirms a procedure-first revenue model where high-frequency, low-reimbursement injection encounters and drug reimbursements dominate over traditional office visit revenue.

Multiple diagnostic and procedural codes are flagged as higher-than-typical volumes in national context: 92014 ranks #1235 of 35415 (97th percentile; notably above typical national volume), 92134 ranks #1099 of 26868 (96th percentile; notably above typical national volume), and 67028 ranks #357 of 4255 (92th percentile; notably above typical national volume). These positions suggest the provider performs retinal imaging and certain laser/injection-related procedures at volumes that are described as notably above typical peers nationally.

The practice maintains some surgical retina capability but it represents a small share of revenue: 67042 (pars plana vitrectomy with ILM peel) generated $52.3K (1.4% of Medicare revenue) and ranks #64 of 1087 (94th percentile; typical, unremarkable volume), while 67036 produced $12.8K (0.3% of Medicare revenue) and ranks #358 of 832 (54th percentile; typical, unremarkable volume). These data point to occasional advanced procedural work supporting a predominantly injection- and imaging-driven practice rather than a high-volume surgical center.

Medicare: Complete Services Breakdown

The CPT/HCPCS codes generating the most Medicare revenue for this provider.

26 rows

CPT/HCPCS Code	Description	Claims	Avg Paid	Revenue
J2777	Injection, faricimab‑svoa, 0.1 mg	43,260	$30	$1.3M
J0178	Injection, aflibercept, 1 mg	1,630	$690	$1.1M
J2778	Injection, ranibizumab, 0.1 mg	4,570	$180	$832.1K
67028	The provider injects a medication into the vitreous chamber of the eye as an isolated procedure or a separate procedure unrelated to any other procedure being performed on the eye.	2,090	$90	$185.8K
92014	An ophthalmologist sees an established patient for a comprehensive level eye examination. Generally, a patient is considered to be "established" if the same physician, or any physician in the group…	1,140	$80	$88.8K
J7312	Injection, dexamethasone, intravitreal implant, 0.1 mg	500	$150	$74.1K
67042	In this procedure, the provider removes vitreous humor, the gelatinous material that gives shape to the eye, using a mechanical cutting tool. He removes the internal limiting membrane of the retina…	60	$840	$52.3K
92134	The provider performs computerized diagnostic imaging of the retina in the posterior segment (back part) of the eye, interprets the data, and provides a report. The service may be on one or both eyes.	1,940	$30	$52.2K
99214	The provider sees an established patient for an office visit or other outpatient visit involving evaluation and management. The visit involves a moderate level of medical decision making, and/or the…	260	$80	$21.6K
92004	The provider performs a comprehensive level ophthalmological evaluation of a new patient and initiates a diagnostic and treatment program for one or more visits.	190	$90	$16.4K

Showing 1–10 of 26

Medicare: Competitive Analysis & Benchmarks

How this provider's Medicare billing volume and revenue compare to other providers nationally and within its state, across 26 CPT/HCPCS codes.

View: State1 / 2

Claims Volume vs. New Mexico Distribution

Christopher Roybal — 5 of 25 codes billed far more than typical (above p95)

p5–p95 (all providers)p25–p75MedianThis providerOutlier

Rank Distribution — New Mexico

Full comparison — all codes billed, vs. state median

26 rows

CPT/HCPCS Code	Rank	Provider Count	Median Claims	Avg Paid	Average Revenue
J0178	7	20	1,100	$690	$816.1K
J2777	4	20	17,340	$30	$653.4K
J2778	1	10	720	$180	$247.3K
67028	3	30	390	$90	$71.6K
J7312	2	10	310	$150	$50.2K
67042	2	10	30	$980	$31.3K
67036	4	10	20	$980	$31.2K
66821	31	40	70	$240	$21.3K
J7999	10	10	320	$60	$18.6K
92014	6	180	130	$70	$18.5K

Showing 1–10 of 26

Related Providers

Other providers that share a Tax Identification Number (TIN) with Christopher Roybal, ranked by combined Medicare and Medicaid revenue.

Provider	State	Taxonomy	Medicare Revenue	Medicaid Revenue
Presbyterian Healthcare Services	NM	General Acute Care Hospital	$0	$345.3M
Presbyterian Healthcare Services	NM	Internal Medicine Physician	$0	$240.8M
Centra Medical Group, LLC	VA	Family Medicine Physician	$0	$60.1M
Presbyterian Healthcare Services	NM	Rural Acute Care Hospital	$0	$47.6M
Eye Associates Of New Mexico Ltd	NM	Ophthalmology Physician	$0	$46.9M
Presbyterian Healthcare Services	NM	Rural Acute Care Hospital	$0	$40.9M
Presbyterian Healthcare Services	NM	Critical Access Hospital	$0	$33.1M
Presbyterian Healthcare Services	NM	General Acute Care Hospital	$0	$21.6M
Presbyterian Healthcare Services	NM	Critical Access Hospital	$0	$20.6M
Thomas Buroker	IA	Medical Oncology Physician	$9.4M	$0

Nearby Providers

Other providers in the same ZIP code as Christopher Roybal, ranked by combined Medicare and Medicaid revenue.

Provider	State	Taxonomy	Medicare Revenue	Medicaid Revenue
New Mexico Consumer Direct Personal Care, LLC	NM	Home Health Agency	$0	$149.8M
Ambercare Hospice, Inc.	NM	Community Based Hospice Care Agency	$0	$28.7M
Advantage Home Care, Inc.	NM	Primary Care Nurse Practitioner	$0	$13.7M
Home Modification Solutions, LLC	NM	In Home Supportive Care Agency	$0	$9.9M
A Childs Voice	NM	Community/Behavioral Health Agency	$0	$5.3M
Allergy Partners, PLLC	NM	Allergy & Immunology Physician	$0	$5M
Armada Skilled Homecare Of New Mexico LLC	NM	Home Health Agency	$0	$3.2M
Anne K. Hempstead D.d.s., P.C.	NM	Pediatric Dentistry	$0	$3M
Autism Specialists LLC	NM	Speech-Language Pathologist	$0	$2.1M
Dr Puneet Rastogi & Associates LLC	NM	Optometrist	$0	$2M

Christopher Roybal — Billing Profile & Reimbursement Data

Sign up for Christopher Roybal — Billing Profile & Reimbursement Data policy alerts

Christopher Roybal — Billing Profile & Reimbursement Data

Sign up for Christopher Roybal — Billing Profile & Reimbursement Data policy alerts

Key Findings

Medicare: Total Revenue Breakdown by CPT/HCPCS Code

Medicare: Complete Services Breakdown

Medicare: Competitive Analysis & Benchmarks

Related Providers

Nearby Providers

Frequently Asked Questions

References